| Characteristic | Variation | No. of patient (Percentage) |
| Age | 0 - 19 | 12 (7.5%) |
| 20 - 29 | 97 (60.6%) | |
| 40 - 59 | 51 (31.9%) | |
| Gender | Male | 53 (33.1%) |
| Female | 107 (66.9%) | |
| Types of surgery | laparoscopic sleeve gastrectomy | 150 (93%) |
| laparoscopic mini-gastric bypass | 9 (5.6%) | |
| laparoscopic roux en y gastric bypass | 1 (0.6%) | |
| Comorbidities | Hypertension | 6.2% |
| Diabetes mellitus | 10% | |
| Dyslipidemia | 6.8% | |
| Asthma | 3.1% | |
| Gastritis | 3.1% | |
| Thyroid's disorder | 5.6% | |
| Contraceptive | 3.1% | |
| Prostate disorder | 1.8% | |
| Psychiatric disorder | 7.5% | |
| Non | 61.25% | |
| Duration of usage of UDCA | 1 - 2 Month | 2 (1.3%) |
| 3 - 4 Month | 3 (1.9%) | |
| 5 - 6 Month | 24 (15%) | |
| 7 - 8 Month | 1 (0.6%) | |
| More than 8 Month | 3 (1.9%) | |
| Non | 127 (79.4%) | |
| US Finding postoperative | Yes | 67 (41.9%) |
| No | 93 (58.1%) | |
| Use of UDCA | Yes | 33 (20.6%) |
| No | 127 (79.4%) | |
| Develop of gall stone post bariatric surgery | Yes | 43 (26.9%) |
| No | 117 (73.1%) |